The global critical limb ischemia treatment market is witnessing substantial growth due to the increasing prevalence of peripheral artery disease (PAD), diabetes, obesity, and cardiovascular disorders worldwide. Critical limb ischemia (CLI) is considered the most severe form of peripheral artery disease and requires immediate medical intervention to prevent tissue loss and amputation. Rising...

The global peptide and anticoagulant drugs market is witnessing substantial growth due to the rising prevalence of cardiovascular diseases, diabetes, cancer, and chronic disorders worldwide. Pharmaceutical companies are increasingly investing in advanced peptide therapeutics and innovative anticoagulant formulations to improve patient outcomes and reduce side effects. Growing awareness...